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ABSTRACT. This study aimed to investigate the potential association 
of TYK2 and STAT3 genes with the susceptibility to Crohn’s disease 
(CD) among Malaysians. DNA samples were obtained from 80 CD 
patients and 100 healthy controls. Polymerase chain reaction-restriction 
fragment length polymorphism methods were employed for genotyping, 
followed by statistical analysis. In our current study, none of the single 
nucleotide polymorphisms of either TYK2 or STAT3 was statistically 
associated with the susceptibility to CD in our local population (P > 
0.05). In contrast, there was a statistically significant association between 
the G/G homozygotes of the STAT3 rs2293152 and the healthy control 
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group (χ2 = 6.229, P < 0.05). In conclusion, our study does not support 
the role of the TYK2 and STAT3 genes influencing CD susceptibility. 
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INTRODUCTION
Crohn’s disease (CD) and ulcerative colitis are 2 major forms of inflammatory bowel 
diseases (IBD), which involve inflammation of both the colon and small intestine (Baumgart, 
2008). CD is characterized by transmural inflammatory lesions that affect virtually any part 
of the gastrointestinal tract (Raelson et al., 2007). In the past few decades, CD was thought to 
be a “western” disease, with higher prevalence rates reported in developed countries, relative 
to those of Asia (Yang et al., 2001; Goh, 2007). However, recent epidemiological studies have 
revealed an increasing trend in CD incidence and prevalence rates in this geographical region 
(Yang et al., 2001; Leong et al., 2004; Ouyang et al., 2005).
Although the etiopathogenesis of this disease remains unknown, its occurrence is 
thought to be triggered by atypical interaction between the intestinal mucosal immune re-
sponse and enteric bacteria. CD is believed to be a multifactorial disease in which both genetic 
and environmental factors underlie its occurrence and development (Hugot et al., 2001). Ge-
netically, the pericentromeric region of human chromosome 16 has been strongly associated 
with CD, as the most prominent CD susceptibility gene; nucleotide-binding and oligomeriza-
tion domain 2/caspase recruitment domain 15 (NOD2/CARD15) is located within the region 
(Hugot et al., 2001; Ogura et al., 2001). The 3 main disease predisposing mutations (R702W, 
G908R and 3020insC) of the NOD2/CARD15 gene were found to be in linkage with the sus-
ceptibility to CD in Caucasian populations (Hugot et al., 2001; Ogura et al., 2001, Cavanaugh, 
2001). However, these mutations are absent in the Malaysian population, with the exception 
of JW1, SNP5 in NOD2/CARD15, DLG5 and IBD5, which were previously reported to be as-
sociated with CD (Chua et al., 2009a, 2011a, 2012). 
There have been a significant number of studies conducted on other possible “candi-
date” genes such as interleukin-23 (IL23), interleukin-23 receptor (IL23R), disks large homolog 5 
(DLG5) and Toll-like receptor 4 (TLR4). IL-23 plays an important role in regulating mucosal host 
defense; thus, it is involved in the pathogenesis of CD (Uhlig et al., 2006; McGovern and Powrie, 
2007). In this context, we proposed that the components of the IL-23/IL-23R signaling pathway, 
i.e., tyrosine kinase 2 (TYK2) and signal transducer and activator of transcription 3 (STAT3), 
could possibly be linked with the susceptibility of CD. The TYK2 gene is located on the p arm 
of chromosome 19, while the STAT3 gene is located on the q arm of chromosome 17 (Lindqvist 
et al., 2000; Sehgal et al., 2003). Hence, in the present study, 3 single nucleotide polymorphisms 
(SNPs) were screened, namely, the TYK2 rs280519, TYK2 rs2304256 and STAT3 rs2293152.
MATERIAL AND METHODS
Sample collection and genomic DNA extraction
A total of 80 CD patients and 100 healthy controls were recruited for this study. The 
collection of blood samples was approved by the Ethics Review Board of University Malaya 
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Medical Centre in Kuala Lumpur, Malaysia (Ethical approval No. 472.55). In addition, in-
formed consent was obtained from each of the volunteers. Subsequently, genomic DNA was 
isolated from the whole blood by using a conventional DNA extraction method as stated previ-
ously (Tan et al., 2010). The isolated DNA was used for genetic analysis.
Genotyping
In this study, the polymerase chain reaction-restriction fragment length polymorphism 
(PCR-RFLP) method was employed in order to investigate the distribution of both STAT3 and 
TYK2 gene polymorphisms, as well as their association with CD susceptibility. The primers 
used to analyze the STAT3 rs2293152, TYK2 rs280519 and TYK2 rs2304256 SNPs are listed in 
Table 1 (Sato et al., 2009). The PCR cycling parameters for the 3 product amplifications were 
set according to PCR conditions described elsewhere (Puah et al., 2007; Chua et al., 2010; Ng 
et al., 2012). These selected primers were then tested via in silico PCR as described previously 
for the prediction of amplicons prior to the actual PCR screening (Teh et al., 2010a,b; Thong 
et al., 2011; Chua et al., 2011b). Subsequent to the PCR step, the amplified products were 
digested with appropriate restriction enzyme (Table 1).
SNP Primer sequence (5'-3') RE
TYK2 rs280519 F: 5ꞌ-CCG CCA TGG TGA AAG TTA GC-3ꞌ Hpy99I
 R: 5ꞌ-ATT TGT GCA GGC CAA GCT GC-3ꞌ
TYK2 rs2304256 F: 5ꞌ-TCA CCA GGC ACT TGT TGT CC-3ꞌ BsmI
 R: 5ꞌ-CGG CTT CCA GCA TGT GTA TG-3ꞌ
STAT3 rs2293152 F: 5ꞌ-TCC CCT GTG ATT CAG ATC CC-3ꞌ HpaII
 R: 5ꞌ-CAT TCC CAC ATC TCT GCT CC-3ꞌ
Table 1. Primers and restriction enzymes (REs) for the analysis of TYK2 rs280519, TYK2 rs2304256 and 
STAT3 rs2293152.
Data analysis
Similar statistical analysis as reported previously has been carried in this study (Chua 
et al., 2009b). The distribution of genetic polymorphisms was obtained by calculating both 
allelic and genotypic frequencies. As for the association testing, statistical analysis was per-
formed by using the chi-square (χ2) test and measuring the odds ratio (OR) values.
RESULTS
In the analysis of the TYK2 rs280519 SNP, all 3 genotypes, i.e., homozygous A/A, 
homozygous G/G and heterozygous A/G, were found in our local population. The presence of 
each genotype was indicated by different restriction fragments observed after Hpy99I enzyme 
digestion (Figure 1). In our study, none of the TYK2 rs280519 genotypes (P > 0.05) were sig-
nificantly associated with either the CD patients or healthy controls (Table 2).
As for the analysis of the TYK2 rs2304256 C/A polymorphisms (Figure 2), the com-
parison between the genotype frequency distribution in CD patients and healthy controls did 
not reveal any significant differences (P > 0.05; Table 2). In addition, we did not observe any 
A/A homozygotes in either the cohort of CD patients or the healthy control group (Table 2).
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Figure 1. PCR-RFLP of TYK2 rs280519. Lane 1 = 50-bp DNA ladder; lane 2 = PCR product without restriction enzyme 
digestion; lane 3 = heterozygous A/G; lane 4 = homozygous A/A; lane 5 = homozygous G/G; lane 6 = DNA blank.
 1 2 3 4 5 6
Genotype CD patient (%) Control (%) χ2 (P) OR (95%CI)
 (N = 80) (N = 100)
TYK2 rs280519
   A/A 13 (16.2) 23 (23.0) 1.266 (P > 0.05) 0.650 
    (0.3054-1.3819)
   G/G 26 (32.5) 29 (29.0) 0.257 (P > 0.05) 1.179 
    (0.6236-2.2284)
   A/G 41 (51.3) 48 (48.0) 0.188 (P > 0.05) 1.139 
    (0.6324-2.0511)
TYK2 rs2304256
   C/C 38 (47.5) 49 (49.0) 0.040 (P > 0.05) 0.942 
    (0.5228-1.6962)
   A/A 0 (0.0) 0 (0.0) - -
   C/A 42 (52.5) 51 (51.0) 0.040 (P > 0.05) 1.062 
    (0.5895-1.9127)
STAT3 rs2293152
   G/G 23 (28.8) 47 (47.0) 6.229 (P > 0.05) 0.455 
    (0.2439-0.8487)
   C/C 16 (20.0) 10 (10.0) 3.596 (P > 0.05) 2.250 
    (0.9592-5.2780)
   G/C 41 (51.2) 43 (43.0) 1.215 (P > 0.05) 1.394 
    (0.7720-2.5158)
Table 2. Genotypic frequencies (N), χ2 (P) and odd ratio (OR) and 95% confidence interval (95%CI) values 
of the TYK2 rs280519, TYK2 rs2304256 and STAT3 rs2293152 polymorphisms in Malaysian Crohn’s disease 
(CD) patients and normal healthy controls.
In contrast, the analysis of the STAT3 rs2293152 polymorphisms revealed more en-
couraging results compared to those of the TYK2 loci. All 3 genotypes were present in all of our 
samples, and exhibited different banding patterns (Figure 3). The homozygous G/G genotype 
was also significantly associated with the healthy control group (χ2 = 6.229, P < 0.05; Table 2). 
This finding might suggest a “protective effect” of this genotype on the development of CD.
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DISCUSSION
With respect to the TYK2 rs280519 SNP G/A gene polymorphisms, statistical analysis 
showed that both the A and G alleles were not significantly associated with CD (χ2 = 0.944, P > 
Figure 2. PCR-RFLP of TYK2 rs2304256. Lane 1 = 50-bp DNA ladder; lane 2 = PCR product without restriction 
enzyme digestion; lane 3 = heterozygous C/A; lane 4 = homozygous C/C; lane 5 = DNA blank.
 1 2 3 4 5
Figure 3. PCR-RFLP of STAT3 rs2293152. Lane 1 = 100-bp DNA ladder; lane 2 = PCR product without restriction 
enzyme digestion; lane 3 = heterozygous G/C; lane 4 = homozygous C/C; lane 5 = homozygous G/G; lane 6 = 
DNA blank.
 1 2 3 4 5 6
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0.05). The G allele, however, exhibited a higher disease penetration (OR = 1.231, 95% confidence 
interval (95%CI) = 0.8094-1.8719) as compared with its A counterpart (OR = 0.812, 95%CI = 
0.5342-1.2355). Perhaps the intronic positioning of this SNP allows it to be spliced out during 
transcription, thus resulting in no correlation between it and susceptibility to CD progression.
Similarly, the TYK2 rs2304256 C and A alleles also did not differ significantly be-
tween both cohorts of samples (χ2 = 0.026, P > 0.05). While the homozygous genotype was 
absent in our results, this was due to the low frequency of the minor A allele. Similar obser-
vations have also been reported in the normal sampling of subjects in various other studies, 
i.e., Spanish (0.269), Japanese (0.38 and 0.345), Caucasians (0.25), and Malaysians (0.255) 
(Cunninghame Graham et al., 2007; Sato et al., 2009; Suarez-Gestal et al., 2009; Kyogoku 
et al., 2009, respectively). TYK2 rs2304256 is essentially a missense polymorphism in exon 
8; hence, it is possible that while we did not observe any association with CD in isolation, it 
could be present on a number of neutrally transmitted low-frequency haplotypes in relation to 
other TYK2 SNPs.
In terms of the STAT3 rs2293152 polymorphisms, the G allele was significantly in-
creased in the control group (χ2 = 7.545, P < 0.05) as compared to the C allele. This correlated 
to its lower OR value of 0.548 and 95%CI of 0.3561-0.8433; hence, perhaps the G allele acts 
as more of a “protective” factor against CD in our local population. This was also evident 
in terms of the GG homozygous carriers (Table 2). While Lovato et al. (2003) have demon-
strated that STAT3 gene polymorphisms are associated with CD when studying intestinal T 
cells from CD patients, we also cannot rule out this possibility, since our current study has only 
focused on a single particular SNP (Lovato et al., 2003). There are a number of other possible 
candidate SNPs within the STAT3 gene that can be studied, including rs4769793, rs744166, 
rs6503695, and rs957970.
Previous studies have demonstrated that the occurrence of IBD involves a complex 
interplay of both innate and adaptive immune responses (Cho, 2008). In this setting, the IL-23/
IL-23R signaling pathway is associated with CD susceptibility. IL-23, IL-23R, IL-12 precur-
sor (IL-12B), IL-12 receptor (IL-12R), the Janus kinase (JAK) families and the STAT families 
are components of this complex network. Thus, both TYK2, a component of the JAK families, 
and STAT3 may play a role in conferring susceptibility to CD (Abraham and Cho, 2009; Wang 
et al., 2009). In the IL-23/IL-23R signaling pathway, TYK2 is activated via various cyto-
kine receptors, and subsequently induces the phosphorylation, homodimerization and nuclear 
translocation of STAT3. As a result, the production of IL-17, natural killer T cells, CD4+ T 
cells, and CD8+ T cells are produced. This signaling cascade plays a central role in first-line 
host defense via the differentiation of naive T cells into TH17 cells (Watford et al., 2004; Na-
kamura et al., 2008). In addition, TYK2 will also bind to the interferon-α receptor (IFN-αR), 
where it is phosphorylated and activated (Richter et al., 1998). The active TYK2 will then 
phosphorylate the IFN-αR to allow further binding of STAT3 and STAT5 (David, 2002).
In our current study, both the TYK2 rs280519 and rs2304256 SNPs were not statisti-
cally associated with CD susceptibility. Interestingly, numerous polymorphisms of the TYK2 
gene have been identified and several case-control studies have been conducted to investigate 
their association with other diseases, including autoimmune diseases. The results thus far are 
conflicting, although this could be due to several study-associated limitations. A meta-analysis 
performed by Tao et al. (2011) that investigated the possible linkage between these SNPs and 
human autoimmune diseases, found that TYK2 rs2304256 was associated with autoimmune 
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diseases, while rs280519 was not. Similarly, there was no statistically significant association 
between STAT3 rs2293152 and CD susceptibility in our Malaysian population. In conclusion, 
our current study demonstrated that both the TYK2 and STAT3 genes were not found to be 
major risk factors related to CD susceptibility in our local population.
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